Drug Topics
OCTOBER 15, 2023
Jean-Venable R. Goode, PharmD, director of the PGY1 Community Based Residency Program at Virginia Commonwealth University, discussed the new vaccine guidelines from ACIP.
Drug Topics
OCTOBER 15, 2023
Lindsay Constantino, president and cofounder of Centennial Pharmacy Services, an LTC pharmacy network, talks about how pharmacies can effectively market their services.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 19, 2023
When pet parents fill a prescription online, they lose the opportunity to consult with a pharmacist.
PharmaVoice
OCTOBER 19, 2023
The actor of “Heroes” and “Star Wars: The Force Awakens” fame is starring in another role as a patient advocate for people with epilepsy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
IDStewardship
OCTOBER 18, 2023
In this article the students from the University of Florida discuss why they started the ChatRx podcast and what their goals are for their new endeavor. Written By: Eisha Ludtke, Pharm.D. Candidate 2024 & Lucas Zhou, Pharm.D. Candidate 2024 Article Posted October 2024 Hello Readers of IDstewardship! My name is Eisha Ludtke, and I am a 4th year pharmacy student at the University of Florida (UF).
Pharmacy Times
OCTOBER 18, 2023
Artificial intelligence and machine learning can significantly benefit managed care pharmacy, specifically in contract reading and interpretation.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
OCTOBER 16, 2023
Billionaire investors and a new crop of longevity biotechs are betting big money on a lifespan-altering tipping point.
STAT
OCTOBER 20, 2023
When she stopped getting her period in March 2022, Daryn Schwartz wasn’t especially concerned. At 42, she had recently come off birth control, and figured her cycles were still adjusting. When it hadn’t come back by the summer, she sought gynecological care, but was told to wait it out. So she did, with no changes. She was having other symptoms, too — fatigue, chronic pain, and difficulty focusing.
Pharmacy Times
OCTOBER 19, 2023
The assistant program director at Mayo Clinic discusses the significance of pharmacists’ role in health care, changes throughout the industry, and her passion for mentoring pharmaceutical students.
Drug Topics
OCTOBER 20, 2023
Despite societal need, stigma around MAT and MOUD still exists.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
OCTOBER 17, 2023
Phenylephrine’s future is up in the air with an FDA committee saying it’s not effective and a class action lawsuit alleging false advertising. What comes next could have big repercussions.
STAT
OCTOBER 20, 2023
A doctor, a patient advocate, and the most powerful figure in the methadone treatment industry presented competing visions for the future of American addiction medicine this week — a conversation that touched on stigma, patients’ rights, and a stark divide in health provider attitudes toward patients with addiction. The debate centered on a single question: whether U.S. doctors should be able to prescribe methadone, a medication used to treat addiction to drugs like fentanyl and he
Pharmacy Times
OCTOBER 19, 2023
There are 3 main medication-related issues for mental health care, which includes polypharmacy, nonadherence to prescribed medication, and underutilization of medications.
Drug Topics
OCTOBER 19, 2023
Veterinarians and veterinarian pharmacists weigh in on issues around working with pet medications.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
OCTOBER 16, 2023
Biopharma leaders pounding away at rare diseases so patients with few other options can have healthier lives.
STAT
OCTOBER 18, 2023
Meta founder Mark Zuckerberg and his wife, pediatrician and philanthropist Priscilla Chan, announced on Wednesday plans to invest $250 million over 10 years to establish a new “biohub” in New York City focused on building a new class of cellular machines that can surveil the body and snuff out disease. The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the coup
Pharmacy Times
OCTOBER 16, 2023
AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.
Drug Topics
OCTOBER 20, 2023
Maternal immunization can prevent RSV in infants.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmaVoice
OCTOBER 17, 2023
A pharma with a massive collection of rainforest-derived plants needs a regulatory win to overcome last year’s financial decline.
Pharmaceutical Technology
OCTOBER 18, 2023
The FDA approved Hyloris’s non-opioid painkiller as the agency increases efforts to mitigate an opioid crisis.
Pharmacy Times
OCTOBER 19, 2023
This finding underlines the need for methods that address multiple genomic alterations and targeted therapies effective in tumors driven by variations in suppressor genes or transcription factors.
Drug Topics
OCTOBER 20, 2023
An ounce of prevention is well worth a pound of cure when it comes to DEA investigations.
PharmaVoice
OCTOBER 18, 2023
Organon is partnering with governments, banks, NGOs and investors on programs to improve women’s health through results-based financing.
STAT
OCTOBER 16, 2023
If you’ve been following the mystery of long Covid since it emerged in 2020, you’ll recall interferons and serotonin have been clues from the start as combatants in the body’s prolonged battles against the virus. Theories about why symptoms persist long after the acute infection has cleared often point to two suspects: viral reservoirs where SARS-CoV-2 lingers and inflammation sparked by the infection that doesn’t subside.
Pharmacy Times
OCTOBER 18, 2023
In the clinical setting, psychedelic medicine has promise as a safe and efficacious treatment for PTSD, TBIs, and other mental health issues.
Drug Topics
OCTOBER 14, 2023
Community pharmacists and their colleagues in the public health space can work together to increase STI testing and treatment in at-risk groups.
Fierce Healthcare
OCTOBER 19, 2023
A new analysis backed by doctor lobbying groups suggest that physician-owned hospitals could have fueled about $1.1 billion in savings across 20 of Medicare’s most expensive conditions in 2019— tho | Lobbying groups in favor of overturning the ban on new physician-owned hospitals outlined broad cost savings if 2019's Medicare patients were treated at such facilities instead of a traditional hospital.
STAT
OCTOBER 16, 2023
Hospitals are frustrated with a nationwide nursing shortage that’s only gotten worse since the pandemic. In 2022, the American Hospital Association quoted an estimate that half a million nurses would leave the field by the end of that year, bringing the total shortage to 1.1 million. At the same time, National Nurses United insists there isn’t a nurse shortage at all.
Pharmacy Times
OCTOBER 20, 2023
The statistically significant and clinically meaningful improvement in disease-free survival is “practice-changing” and may represent a “paradigm shift” in treatment, according to experts.
Drug Topics
OCTOBER 14, 2023
Remodeling your pharmacy is about much more than a new paint job and getting rid of old carpets.
Fierce Pharma
OCTOBER 16, 2023
As the coronavirus outbreak has shifted to the endemic phase, drugmakers have warned of a drop in demand for COVID-19 products, with the impact coming into focus during the fall vaccination season. | Pfizer has slashed its 2023 revenue projection by $9 billion because of declining demand for COVID products. The company now expects sales to reach between $58 billion and $61 billion, down from a prior range of $67 billion to $70 billion.
STAT
OCTOBER 17, 2023
The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam. Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.
Pharmacy Times
OCTOBER 20, 2023
Penbraya (Pfizer Inc) is the first and only approved pentavalent vaccine that confers protection against the most common meningococcal serogroups—A, B, C, W-135, and Y, in individuals 10 through 25 years of age.
Expert insights. Personalized for you.
551 
Let's personalize your content